Publication | Closed Access

Intrauterine administration of human chorionic gonadotropin improves the live birth rates of patients with repeated implantation failure in frozen-thawed blastocyst transfer cycles by increasing the percentage of peripheral regulatory T cells

OocyteInfertilityDevelopmental BiologyFertilityIntrauterine AdministrationHuman Chorionic GonadotropinReproductive HealthGynecologyReproductive BiologyPublic HealthMedicineRepeated Implantation FailureHuman Reproduction